Not recommended for Non-cosmetic Breast Surgery
Major breast surgery | Minor breast surgery | |
Pre-operative
not recommended |
– Conventional NSAIDs (Grade B) because of inconsistent procedure-specific and transferable evidence for benefit of pre- vs. postoperative administration, and increased risk of bleeding
– Corticosteroids for analgesia (Grade D) due to insufficient procedure-specific evidence
– COX-2-selective inhibitors (except in short breast surgery procedures) (Grade D) as transferable evidence shows inconsistent benefit of pre- vs. postoperative administration, and there is no procedure-specific evidence
– NMDA antagonists
o Dextromethorphan (Grade B) due to limited procedure-specific evidence
o Magnesium for analgesia (Grade B) due to transferable evidence showing a lack of analgesic effects
– Paracetamol (except in short breast surgery procedures) (Grade D) as there is no procedure-specific or transferable evidence to show whether pre-operative administration has any analgesic benefit compared with postoperative administration
– Strong opioids (Grade D) due to no procedure-specific evidence of an analgesic benefit of pre- vs. postincisional administration
– Thoracic epidural analgesia (Grade D) due to the risk of complications
– Electro-acupoint stimulation (Grade D) due to limited procedure-specific and transferable evidence |
– Gabapentinoids (Grade D) because pain intensity is commonly not severe enough to justify an adjuvant to the usual analgesic agents
– Conventional NSAIDs (Grade D) because of inconsistent procedure-specific and transferable evidence for benefit of pre- vs. postoperative administration
– Corticosteroids for analgesia (Grade D) due to insufficient procedure-specific evidence
– COX-2-selective inhibitors (except in short breast surgery procedures) (Grade D) as transferable evidence shows inconsistent benefit of pre- vs. postoperative administration, and there is no procedure-specific evidence
– NMDA antagonists
o Dextromethorphan (Grade B) due to limited procedure-specific evidence
o Magnesium for analgesia (Grade B) due to transferable evidence showing a lack of analgesic effects
– Paracetamol (except in short breast surgery procedures) (Grade D) as there is no procedure-specific or transferable evidence to show whether pre-operative administration has any analgesic benefit compared with postoperative administration
– Strong opioids (Grade D) due to no procedure-specific evidence of an analgesic benefit of pre- vs. postincisional administration
– Paravertebral block (Grade D) because of the risk of complications
– Thoracic epidural analgesia (Grade D) due to the risk of complications
– Electro-acupoint stimulation (Grade D) due to limited procedure-specific and transferable evidence |
Intra-operative
not recommended |
– Corticosteroids for analgesia (Grade D) due to insufficient procedure-specific evidence
– Adenosine (Grade D) because of limited procedure-specific and transferable evidence
– Intercostal block (Grade D) because of insufficient procedure-specific evidence
– High concentrations of oxygen (Grade B) due to negative procedure-specific evidence
– Electro-acupoint stimulation (Grade D) due to limited procedure-specific and transferable evidence |
– Corticosteroids for analgesia (Grade D) due to insufficient procedure-specific evidence
– Adenosine (Grade D) because of limited procedure-specific and transferable evidence
– Intercostal block (Grade D) because of insufficient procedure-specific evidence
– High concentrations of oxygen (Grade B) due to negative procedure-specific evidence
– Electro-acupoint stimulation (Grade D) due to limited procedure-specific and transferable evidence |
Postoperative
not recommended |
– Mexiletine (Grade D) because of limited and conflicting procedure-specific evidence
– Paracetamol alone for high intensity pain (Grade B) due to insufficient analgesic efficacy
– Strong opioids for low-moderate pain (Grade B) because of a risk of emetic and other side-effects
– IM administration of strong opioids (Grade B) because of transferable evidence showing unfavourable pharmacokinetics, injection-associated pain, and patient dissatisfaction
– Antibiotics for analgesia (Grade D) due to limited procedure-specific evidence showing inconsistent results
– Continuous paravertebral block (Grade D) due to limited procedure-specific evidence
– Thoracic epidural analgesia (Grade D) due to the risk of complications
– Topical administration of local anaesthetics (Grade D) due to inconsistent procedure-specific evidence
– Wound application of conventional NSAID via drain (Grade B) because of procedure-specific and transferable evidence showing a lack of analgesic benefit
– High concentrations of oxygen (Grade B) due to negative procedure-specific evidence
|
– Gabapentinoids (Grade B) because pain intensity is commonly not severe enough to justify an adjuvant to the usual analgesic agents
– Mexiletine (Grade D) because of limited and conflicting procedure-specific evidence
– Paracetamol alone for high intensity pain (Grade B) due to insufficient analgesic efficacy
– Strong opioids for low-moderate pain (Grade B) because of a risk of emetic and other side-effects
– IM administration of strong opioids (Grade B) because of transferable evidence showing unfavourable pharmacokinetics, injection-associated pain, and patient dissatisfaction
– Antibiotics for analgesia (Grade D) due to limited procedure-specific evidence showing inconsistent results
– Continuous paravertebral block (Grade D) because of the risk of complications
– Thoracic epidural analgesia (Grade D) due to the risk of complications
– Topical administration of local anaesthetics (Grade D) due to inconsistent procedure-specific data
– Wound application of conventional NSAID via drain (Grade B) because of procedure-specific and transferable evidence showing a lack of analgesic benefit
– High concentrations of oxygen (Grade B) due to negative procedure-specific evidence |